Author

S.-G. Chi

Observed names: S.-G Chi, S.G. Chi, Sung Chi

Institution: Korea University

Observed institutions: Korea University, Kyung Hee University, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis

OpenAlex ID: A5110201202

p53 in Prostate Cancer: Frequent Expressed Transition Mutations

1994 · S.-G. Chi, R. W. deVere White, et al. · JNCI Journal of the National Cancer Institute · 175

Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways

2004 · J.I. Park, M.G. Lee, et al. · Urologic Oncology Seminars and Original Investigations · 60

p53 Abnormalities in Primary Prostate Cancer: Single-Strand Conformation Polymorphism Analysis of Complementary DNA in Comparison With Genomic DNA

1997 · P. H. Gumerlock, S.-G. Chi, et al. · JNCI Journal of the National Cancer Institute · 53

Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma

2002 · K.-S Chae, B.-K Ryu, et al. · European Journal of Cancer · 19

P53 mutations in Ewing's sarcoma

2001 · Yong-Koo Park, Sung Chi, et al. · Oncology Reports · 15

Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma

2001 · Yong-Koo Park, Hye Park, et al. · International Journal of Oncology · 13

Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis (vol 21, pg 609, 2011)

2011 · Zhou Wj, ZH Geng, et al. · 8

Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma

2001 · Yong-Koo Park, Chang Cho, et al. · International Journal of Oncology · 8

Mutational Alterations of the p16CDKN2A Tumor Suppressor Gene Have Low Incidence in Mesenchymal Chondrosarcoma

2001 · D.K. Bae, Y-K. Park, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2

XAF1 enhances temozolomide induced autophagic cell death through AMPK signaling pathway

2019 · M. Lee, K.-P. Ko, et al. · Annals of Oncology · 1

XAF1 assembles a destructive complex to induce BRCA1-mediated apoptosis via suppressing ERa and switching estrogen function

2019 · S.-H. Jang, J.-S. Lim, et al. · Annals of Oncology · 1

XAF1 and ZNF313 complex stimulates ER stress-induced apoptosis via direct GRP78 inhibition

2019 · S. Jang, K.-W. Lee, et al. · Annals of Oncology · 1

NORE1A induces a feedback termination of TNF signaling by antagonizing TNFR1 through ITCH-mediated destruction complex

2019 · J. Ahn, K.-P. Ko, et al. · Annals of Oncology

Works count: 13

Citation count: 356

H-index: 8

I10-index: 6